Latest Latent autoimmune diabetes Stories
An international team of researchers led by Imperial College London has identified six new genetic variants associated with type-2 diabetes in South Asians. The findings, published in Nature Genetics, give scientists new leads in the search for diagnostic markers and drug targets to prevent and treat this major disease. People of South Asian ancestry are up to four times more likely than Europeans to develop type 2 diabetes, which is a major risk factor for heart disease and stroke. Around...
ATLANTA, Aug. 17, 2011 /PRNewswire/ -- The 14th annual Victory Over Diabetes event, hosted by the American Diabetes Association (the Association), will take place in Atlanta on August 20, featuring educational workshops, free health screenings and resources designed to encourage African Americans to take control of their health and better manage their type 2 diabetes. In attendance will be Eli Lilly and Company's Fearless African-Americans Connected and Empowered (F.A.C.E.) Diabetes...
(Ivanhoe Newswire)--Managing your diabetes could be as simple as using your mobile phone. A study conducted by the University of Maryland School of Medicine is the first of its kind to examine mobile health technology. Mobile phones are improving nurse-patient communication and monitoring health through innovative applications that are expected to increase in use over time. The mobile phone may now be contributing to health care as suggested by this recent study. Researchers found that a...
Study shows building muscle can lower person's risk of insulin resistanceA recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM) found that the greater an individual's total muscle mass, the lower the person's risk of having insulin resistance, the major precursor of type 2 diabetes.With recent dramatic increases in obesity worldwide, the prevalence of diabetes, a major source of cardiovascular morbidity, is expected to...
HIGH WYCOMBE, England, July 21, 2011 /PRNewswire/ -- Using the waterproof* Animas(R) Vibe(TM) Insulin Pump and CGM System, People with Diabetes to Participate in Channel Swim Relay Six swimmers congregate along the Dover coastline today, to participate in a 17-hour relay swim across the English Channel to France. The relay event, sponsored by Animas(R),aims to raise money for the Juvenile Diabetes Research Foundation (JDRF) and celebrate people with diabetes performing...
JDRF says Pending Artificial Pancreas Guidance is FDA's Opportunity to Turn the Tide NEW YORK, July 20, 2011 /PRNewswire-USNewswire/ -- The Juvenile Diabetes Research Foundation (JDRF) welcomed Congress's attention today to the important issue of medical device regulatory reform and reiterated the life-changing difference the FDA's pending artificial pancreas guidance will make in the lives of millions of individuals with type 1 diabetes across the country. The hearing, "FDA Medical Device...
TAMPA, Fla., July 14, 2011 /PRNewswire-USNewswire/ -- In an effort to raise awareness of the effects of excess weight on overall health, the OAC has released a new series of educational brochures. Millions of Americans are affected by excess weight, obesity and severe obesity. One of the most common conditions related to excess weight is type 2 diabetes. Approximately 25.8 million Americans have type 1 and type 2 diabetes.(1) Type 2 diabetes is the most common type, accounting for an...
WORCESTER, Mass. and TORONTO, July 8, 2011 /PRNewswire/ -- Generex Biotechnology Corporation (OTC Bulletin Board: GNBT) (www.generex.com) today announced preliminary clinical results of two major trials using the Generex Oral-lyn(TM) formulation that will be used for registration and marketing. Unlike prior reported results from studies using older versions of the formulation, the combined data from the now completed 084 Trial in Type 1 patients and the Prevoral Trial in patients with...
ORLANDO, Fla., July 7, 2011 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, and the advocacy organization Children with Diabetes, Inc. (CWD) today announced a two-year partnership to develop and distribute resources that will help newly diagnosed children with type 1 diabetes adjust to their new lifestyle. Every year, approximately 15,600 children and adolescents in the United States are diagnosed with type 1 diabetes, a condition that occurs when the body does not produce...
ROCKVILLE, Md., June 28, 2011 /PRNewswire/ -- MacroGenics, Inc., a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, announced the publication in The Lancet of results from Protege, a Phase 3 clinical study of teplizumab in type 1 diabetes. Exploratory, post-hoc analyses suggest that teplizumab, an anti-CD3 monoclonal antibody, when used in a 14-day full dose regimen, preserves C-peptide and increases the...
